Irgm2 and Gate-16 cooperatively dampen Gram-negative bacteria-induced caspase-11 response.


Journal

EMBO reports
ISSN: 1469-3178
Titre abrégé: EMBO Rep
Pays: England
ID NLM: 100963049

Informations de publication

Date de publication:
05 11 2020
Historique:
received: 07 05 2020
revised: 11 09 2020
accepted: 25 09 2020
pubmed: 31 10 2020
medline: 28 4 2021
entrez: 30 10 2020
Statut: ppublish

Résumé

Inflammatory caspase-11 (rodent) and caspases-4/5 (humans) detect the Gram-negative bacterial component LPS within the host cell cytosol, promoting activation of the non-canonical inflammasome. Although non-canonical inflammasome-induced pyroptosis and IL-1-related cytokine release are crucial to mount an efficient immune response against various bacteria, their unrestrained activation drives sepsis. This suggests that cellular components tightly control the threshold level of the non-canonical inflammasome in order to ensure efficient but non-deleterious inflammatory responses. Here, we show that the IFN-inducible protein Irgm2 and the ATG8 family member Gate-16 cooperatively counteract Gram-negative bacteria-induced non-canonical inflammasome activation, both in cultured macrophages and in vivo. Specifically, the Irgm2/Gate-16 axis dampens caspase-11 targeting to intracellular bacteria, which lowers caspase-11-mediated pyroptosis and cytokine release. Deficiency in Irgm2 or Gate16 induces both guanylate binding protein (GBP)-dependent and GBP-independent routes for caspase-11 targeting to intracellular bacteria. Our findings identify molecular effectors that fine-tune bacteria-activated non-canonical inflammasome responses and shed light on the understanding of the immune pathways they control.

Identifiants

pubmed: 33124769
doi: 10.15252/embr.202050829
pmc: PMC7645206
doi:

Substances chimiques

Autophagy-Related Protein 8 Family 0
GABARAPL2 protein, human 0
Inflammasomes 0
Lipopolysaccharides 0
Caspases EC 3.4.22.-
Caspases, Initiator EC 3.4.22.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e50829

Subventions

Organisme : European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
Organisme : EC | H2020 | H2020 Priority Excellent Science | H2020 European Research Council (ERC)
ID : INFLAME 804249
Organisme : Fondation pour la Recherche Médicale (FRM)
ID : AJE20151034460
Organisme : ATIP-Avenir
Organisme : Research ProGram on Emerging and Re-emerging Infectious Diseases
ID : JP19fk0108047
Organisme : Japanese Initiative for Progress of Research on Infectious Diseases for Global Epidemic
ID : JP19fm0208018
Organisme : MEXT | JST | Strategic International Collaborative Research Program (SICORP)
ID : 19jm0210067h
Organisme : Grant-in-Aid for Scientific Research on Innovative Areas
ID : 19H04809
Organisme : Grant-in-Aid for Scientific Research
ID : 18KK0226
Organisme : Grant-in-Aid for Scientific Research
ID : 18H02642
Organisme : Ministry of Education, Culture, Sports, Science and Technology of Japan
ID : 19H00970

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2020 The Authors.

Références

J Clin Invest. 2017 Nov 1;127(11):4124-4135
pubmed: 28990935
Nature. 2006 Mar 9;440(7081):237-41
pubmed: 16407889
Nat Commun. 2016 Nov 03;7:13292
pubmed: 27808091
Eur J Immunol. 2015 Oct;45(10):2927-36
pubmed: 26173909
Nature. 2016 Jul 06;535(7610):153-8
pubmed: 27383986
Nat Immunol. 2019 Mar;20(3):276-287
pubmed: 30692621
Cell. 1998 Feb 20;92(4):501-9
pubmed: 9491891
J Mol Biol. 2016 Aug 28;428(17):3495-513
pubmed: 27181197
J Exp Med. 2016 Oct 17;213(11):2365-2382
pubmed: 27697835
Cell Host Microbe. 2012 Oct 18;12(4):432-44
pubmed: 23084913
EMBO J. 2016 Aug 15;35(16):1766-78
pubmed: 27418190
Nature. 2012 Oct 11;490(7419):288-91
pubmed: 22895188
Science. 2018 Nov 23;362(6417):956-960
pubmed: 30467171
EMBO Rep. 2020 Nov 5;21(11):e50829
pubmed: 33124769
Proc Natl Acad Sci U S A. 2014 Apr 22;111(16):6046-51
pubmed: 24715728
BMB Rep. 2016 Aug;49(8):424-30
pubmed: 27418283
Cell. 2016 Oct 6;167(2):382-396.e17
pubmed: 27693356
Nat Immunol. 2019 May;20(5):527-533
pubmed: 30962589
PLoS Pathog. 2017 Oct 2;13(10):e1006630
pubmed: 28968459
Sci Signal. 2019 May 21;12(582):
pubmed: 31113851
Mamm Genome. 2018 Aug;29(7-8):593-602
pubmed: 29982912
PLoS Pathog. 2013 Sep;9(9):e1003538
pubmed: 24068918
EMBO Rep. 2020 Nov 5;21(11):e50830
pubmed: 33124745
Cells. 2019 Jan 21;8(1):
pubmed: 30669622
Nat Immunol. 2020 Aug;21(8):880-891
pubmed: 32541830
Nat Commun. 2020 Jun 24;11(1):3276
pubmed: 32581219
Science. 2013 Feb 22;339(6122):975-8
pubmed: 23348507
BMC Biol. 2016 Apr 20;14:33
pubmed: 27098192
EMBO J. 2000 Apr 3;19(7):1494-504
pubmed: 10747018
Eur J Immunol. 2015 Oct;45(10):2911-7
pubmed: 26174085
Science. 2013 Sep 13;341(6151):1246-9
pubmed: 23887873
J Exp Med. 1999 Aug 16;190(4):523-34
pubmed: 10449523
Mol Cell. 2019 Feb 7;73(3):429-445.e7
pubmed: 30612879
Microbiol Mol Biol Rev. 2018 Sep 12;82(4):
pubmed: 30209070
J Biol Chem. 2002 Dec 6;277(49):47834-43
pubmed: 12324469
Virulence. 2019 Dec;10(1):352-362
pubmed: 30978154
Nat Immunol. 2015 May;16(5):467-75
pubmed: 25774715
PLoS Pathog. 2018 Dec 27;14(12):e1007519
pubmed: 30589883
PLoS One. 2010 Jan 13;5(1):e8648
pubmed: 20072621
EMBO J. 2019 Jul 1;38(13):e100926
pubmed: 31268602
Nat Immunol. 2015 May;16(5):476-484
pubmed: 25774716
Immunity. 2012 Aug 24;37(2):302-13
pubmed: 22795875
Virulence. 2014 Jan 1;5(1):143-53
pubmed: 24022070
Immunity. 2018 Oct 16;49(4):740-753.e7
pubmed: 30314759
Biosci Rep. 2018 Nov 15;38(6):
pubmed: 30126853
Nature. 2014 May 15;509(7500):366-70
pubmed: 24739961
EMBO Rep. 2019 Sep;20(9):e48235
pubmed: 31353801
Nat Commun. 2018 Jan 16;9(1):242
pubmed: 29339744
EMBO J. 2018 Mar 15;37(6):
pubmed: 29459437
mBio. 2017 Oct 3;8(5):
pubmed: 28974614
EMBO J. 2020 Jul 1;39(13):e104926
pubmed: 32510692
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450
pubmed: 30395289
J Cell Biol. 2016 Dec 19;215(6):857-874
pubmed: 27864321
Cell. 1995 Feb 10;80(3):401-11
pubmed: 7859282
J Immunol. 2018 Jan 15;200(2):607-622
pubmed: 29203515
Autophagy. 2019 Sep;15(9):1645-1647
pubmed: 31177914
Nature. 2015 Oct 29;526(7575):666-71
pubmed: 26375259
Nat Immunol. 2017 Aug;18(8):899-910
pubmed: 28604719
Immunity. 2019 Dec 17;51(6):983-996.e6
pubmed: 31836429
Nat Commun. 2018 Apr 19;9(1):1558
pubmed: 29674694
Proc Natl Acad Sci U S A. 2016 Jul 12;113(28):7858-63
pubmed: 27339137
EMBO J. 2019 Nov 15;38(22):e101994
pubmed: 31625181
Autophagy. 2016 Jul 2;12(7):1153-67
pubmed: 27172324
Curr Opin Immunol. 2015 Feb;32:78-83
pubmed: 25621708
Nature. 2011 Oct 16;479(7371):117-21
pubmed: 22002608
Nature. 2015 Oct 29;526(7575):660-5
pubmed: 26375003
Cell. 2016 May 19;165(5):1106-1119
pubmed: 27156449
Proc Natl Acad Sci U S A. 2015 Oct 13;112(41):E5628-37
pubmed: 26417105
Infect Immun. 2017 Sep 20;85(10):
pubmed: 28784930
Proc Natl Acad Sci U S A. 2017 Feb 28;114(9):E1698-E1706
pubmed: 28193861
Science. 2013 Sep 13;341(6151):1250-3
pubmed: 24031018
JCI Insight. 2017 Aug 17;2(16):
pubmed: 28814662
J Exp Med. 2018 Sep 3;215(9):2279-2288
pubmed: 30135078
Autophagy. 2019 May;15(5):796-812
pubmed: 30676840
PLoS Pathog. 2013;9(6):e1003414
pubmed: 23785284
Cell Rep. 2018 Jul 3;24(1):155-168.e5
pubmed: 29972777
Sci Immunol. 2018 Aug 24;3(26):
pubmed: 30143554
Infect Immun. 2015 Dec;83(12):4740-9
pubmed: 26416908

Auteurs

Elif Eren (E)

Institute of Pharmacology and Structural Biology (IPBS), CNRS, UMR5089, University of Toulouse, Toulouse, France.

Rémi Planès (R)

Institute of Pharmacology and Structural Biology (IPBS), CNRS, UMR5089, University of Toulouse, Toulouse, France.

Salimata Bagayoko (S)

Institute of Pharmacology and Structural Biology (IPBS), CNRS, UMR5089, University of Toulouse, Toulouse, France.

Pierre-Jean Bordignon (PJ)

Institute of Pharmacology and Structural Biology (IPBS), CNRS, UMR5089, University of Toulouse, Toulouse, France.

Karima Chaoui (K)

Institute of Pharmacology and Structural Biology (IPBS), CNRS, UMR5089, University of Toulouse, Toulouse, France.
Mass Spectrometry Core Facility, Institute of Pharmacology and Structural Biology (IPBS), CNRS, UMR5089, University of Toulouse, Toulouse, France.

Audrey Hessel (A)

Institute of Pharmacology and Structural Biology (IPBS), CNRS, UMR5089, University of Toulouse, Toulouse, France.

Karin Santoni (K)

Institute of Pharmacology and Structural Biology (IPBS), CNRS, UMR5089, University of Toulouse, Toulouse, France.

Miriam Pinilla (M)

Institute of Pharmacology and Structural Biology (IPBS), CNRS, UMR5089, University of Toulouse, Toulouse, France.

Brice Lagrange (B)

CIRI, Centre International de Recherche en Infectiologie, Inserm, U1111, CNRS, UMR5308, École Normale Supérieure de Lyon, Université Claude Bernard Lyon 1, Univ Lyon, Lyon, France.

Odile Burlet-Schiltz (O)

Institute of Pharmacology and Structural Biology (IPBS), CNRS, UMR5089, University of Toulouse, Toulouse, France.
Mass Spectrometry Core Facility, Institute of Pharmacology and Structural Biology (IPBS), CNRS, UMR5089, University of Toulouse, Toulouse, France.

Jonathan C Howard (JC)

Fundação Calouste Gulbenkian, Instituto Gulbenkian de Ciência, Oeiras, Portugal.

Thomas Henry (T)

CIRI, Centre International de Recherche en Infectiologie, Inserm, U1111, CNRS, UMR5308, École Normale Supérieure de Lyon, Université Claude Bernard Lyon 1, Univ Lyon, Lyon, France.

Masahiro Yamamoto (M)

Department of Immunoparasitology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
Laboratory of Immunoparasitology, WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan.

Etienne Meunier (E)

Institute of Pharmacology and Structural Biology (IPBS), CNRS, UMR5089, University of Toulouse, Toulouse, France.

Articles similaires

Endometriosis Female Humans Animals Mice
Humans Stomach Neoplasms Macrophages Tumor Microenvironment Disease Progression
Sirtuin 1 Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha Animals Resveratrol Rats
NLR Family, Pyrin Domain-Containing 3 Protein Autophagy Inflammasomes Interleukin-1beta Animals

Classifications MeSH